Adjuvant chemotherapy for stage II colon cancer: who really needs it

about

Adjuvant chemotherapy for stage II colon cancer: who really needs it

Item

http://www.wikidata.org/entity/Q58795668

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Adjuvant chemotherapy for stage II colon cancer: who really needs it

@en

Adjuvant chemotherapy for stage II colon cancer: who really needs it

@nl

type

Item

label

Adjuvant chemotherapy for stage II colon cancer: who really needs it

@en

Adjuvant chemotherapy for stage II colon cancer: who really needs it

@nl

prefLabel

Adjuvant chemotherapy for stage II colon cancer: who really needs it

@en

Adjuvant chemotherapy for stage II colon cancer: who really needs it

@nl

P1476

Adjuvant chemotherapy for stage II colon cancer: who really needs it

@en

P2093

Aiying Li

http://www.w3.org/2001/XMLSchema#string

Fen Wang

http://www.w3.org/2001/XMLSchema#string

Hui Yang

http://www.w3.org/2001/XMLSchema#string

Huihui Wang

http://www.w3.org/2001/XMLSchema#string

Qi Chen

http://www.w3.org/2001/XMLSchema#string

Quanan Zhang

http://www.w3.org/2001/XMLSchema#string

Yan Yang

http://www.w3.org/2001/XMLSchema#string

Yang Yang

http://www.w3.org/2001/XMLSchema#string

Ying Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Utility of the SEER-Medicare data to identify chemotherapy use.

Identifying cancer relapse using SEER-Medicare data.

Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials.

Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials.

Racial differences and disparities in cancer care and outcomes: where's the rub?

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Epidemiology of Medicare abuse: the example of power wheelchairs.

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group.

P304

2509-2520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S160886

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30123000

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6087016

http://www.w3.org/2001/XMLSchema#string